Intravenous colistin combination antimicrobial treatment vs. monotherapy: a systematic review and meta-analysis
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine
Reference60 articles.
1. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections;Li;Lancet Infect Dis,2006
2. Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections;Falagas;Clin Infect Dis,2005
3. The safety of polymyxin antibiotics;Kelesidis;Expert Opin Drug Saf,2015
4. Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus;Nation;Lancet Infect Dis,2015
5. Multicomponent antibiotic substances produced by fermentation: implications for regulatory authorities, critically ill patients and generics;Brink;Int J Antimicrob Agents,2014
Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Key summary of German national guideline for adult patients with nosocomial pneumonia- Update 2024 Funding number at the Federal Joint Committee (G-BA): 01VSF22007;Infection;2024-08-08
2. Monotherapy vs combination therapy in patients with Klebsiella pneumoniae bloodstream infection: A systematic review and meta-analysis;Journal of Infection and Chemotherapy;2024-05
3. Guidelines for Antibacterial Treatment of Carbapenem-Resistant Enterobacterales Infections;Infection & Chemotherapy;2024
4. Efficacy of Intravenous Colistin Monotherapy Versus Colistin Combined With Meropenem in Patients With Multidrug-Resistant Infections: A Retrospective Observational Study;Cureus;2023-10-19
5. In vitro, in vivo and clinical studies comparing the efficacy of ceftazidime-avibactam monotherapy with ceftazidime-avibactam-containing combination regimens against carbapenem-resistant Enterobacterales and multidrug-resistant Pseudomonas aeruginosa isolates or infections: a scoping review;Frontiers in Medicine;2023-09-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3